StockData
Kardigan, Inc. logo

Kardigan, Inc. (KARD) stock

KARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$13.19+0.34 (+2.65%)

Close on Nov 17, 2026Market cap $1.23BP/E –Yield –

Kardigan r&d expenses

Research and development expenses are spending on new products and technology.

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$64.36M–
Q2 FY2026Jun 30, 2026$56.37M–
Q3 FY2025Sep 30, 2025$49.14M–
Q2 FY2025Jun 30, 2025$35.84M–

More Kardigan figures

See a number that looks wrong?